Mehmet Birhan Yılmaz1, Ahmet Çelik2, Yüksel Çavuşoğlu3, Lütfü Bekar4, Ersel Onrat5, Mehmet Eren6, Merih Kutlu7, Kenan Yalta8, Ahmet Temizhan9, Barış Kılıçaslan10, Hasan Güngör11, Mahmut Açıkel9, Mesut Demir12, Ramazan Akdemir13, Mehdi Zoghi14, Lale Tokgözoğlu15. 1. Department of Cardiology, Faculty of Medicine, Dokuz Eylül University, İzmir. 2. Department of Cardiology, Faculty of Medicine, Mersin University, Mersin. 3. Department of Cardiology, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir. 4. Department of Cardiology, Faculty of Medicine, Hitit University, Çorum. 5. Department of Cardiology, Faculty of Medicine, Kocatepe University, Afyon. 6. Cardiology Clinic, Siyami Ersek Education and Research Hospital, Istanbul. 7. Department of Cardiology, Faculty of Medicine, Karadeniz Teknik University, Trabzon. 8. Department of Cardiology, Faculty of Medicine, Trakya University, Edirne. 9. Cardiology Clinic, Türkiye Yuksek Ihtisas Education and Research Hospital, Ankara. 10. Cardiology Clinic, Tepecik Education and Research Hospital, Izmir. 11. Department of Cardiology, Faculty of Medicine, Adnan Menderes University, Aydın. 12. Department of Cardiology, Faculty of Medicine, Çukurova University, Adana. 13. Department of Cardiology, Faculty of Medicine, Sakarya University, Sakarya. 14. Department of Cardiology, Faculty of Medicine, Ege University, Izmir. 15. Department of Cardiology, Faculty of Medicine, Hacettepe University, Ankara.
Abstract
OBJECTIVE: Heart failure (HF) is an important health issue of the 21st century and the prevalence in Turkey has been reported as 2.9%. A national profile, frequency data, characteristics of different phenotypes, and risk factors have not yet been well established. The Snapshot Evaluation of Heart Failure Patients in Turkey (SELFIE-TR) was an analysis of a representative sample of HF patients from Turkey. METHODS: A total of 23 centers with at least 2 cardiologists from the 12 NUTS-1 regions of Turkey were invited to participate in the research. The contributing centers shared the data of a consecutive enrollment of HF patients, as confirmed by an investigator, on a pre-selected day of each week for the month of October or November of 2015. RESULTS: The mean age of the entire cohort was 63.3+-13.3 years (male/female ratio: 751/303, 71.3%/28.7%). There were 712 acute HF patients and 342 chronic HF patients. The total number of HF patients with reduced ejection fraction (HFrEF), heart failure with mid-range ejection fraction, and heart failure with preserved ejection fraction was 801 (75%), 176 (16.7%), and 77 (7.3%), respectively. The patients with chronic HF were younger than those with acute HF (61.1+-13.3 years vs 67.9+-12.1 years; p<0.001). Among the whole cohort, hypertension was observed in 46%, diabetes mellitus was present in 27.5%, chronic obstructive pulmonary disease was present in 12.8%, and previous myocardial infarction was noted in 45.2%. In patients with HFrEF, the use of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, a beta blocker, or a mineralocorticoid receptor antagonist was noted in 74.7%, 89.7%, and 60.9%, respectively. CONCLUSION: The SELFIE-TR findings provide important insight, since it is the first study to make a snapshot of HF patients in our country. These data may help to create standardized prevention and treatment strategies.
OBJECTIVE:Heart failure (HF) is an important health issue of the 21st century and the prevalence in Turkey has been reported as 2.9%. A national profile, frequency data, characteristics of different phenotypes, and risk factors have not yet been well established. The Snapshot Evaluation of Heart FailurePatients in Turkey (SELFIE-TR) was an analysis of a representative sample of HF patients from Turkey. METHODS: A total of 23 centers with at least 2 cardiologists from the 12 NUTS-1 regions of Turkey were invited to participate in the research. The contributing centers shared the data of a consecutive enrollment of HF patients, as confirmed by an investigator, on a pre-selected day of each week for the month of October or November of 2015. RESULTS: The mean age of the entire cohort was 63.3+-13.3 years (male/female ratio: 751/303, 71.3%/28.7%). There were 712 acute HF patients and 342 chronic HF patients. The total number of HF patients with reduced ejection fraction (HFrEF), heart failure with mid-range ejection fraction, and heart failure with preserved ejection fraction was 801 (75%), 176 (16.7%), and 77 (7.3%), respectively. The patients with chronic HF were younger than those with acute HF (61.1+-13.3 years vs 67.9+-12.1 years; p<0.001). Among the whole cohort, hypertension was observed in 46%, diabetes mellitus was present in 27.5%, chronic obstructive pulmonary disease was present in 12.8%, and previous myocardial infarction was noted in 45.2%. In patients with HFrEF, the use of an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, a beta blocker, or a mineralocorticoid receptor antagonist was noted in 74.7%, 89.7%, and 60.9%, respectively. CONCLUSION: The SELFIE-TR findings provide important insight, since it is the first study to make a snapshot of HF patients in our country. These data may help to create standardized prevention and treatment strategies.